Vivanza Biosciences P/E Ratio
Vivanza Biosciences (VIVANZA) P/E ratio is not applicable — EPS (TTM) ₹-0.17. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-0.17
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | 0.14 | 1 | Profit |
| Mar 2025 | -0.25 | -1 | Loss |
| Jun 2025 | 0.02 | 0 | Profit |
| Mar 2024 | -0.10 | 0 | Loss |
| Jun 2024 | 0.07 | 0 | Profit |
| Dec 2024 | 0.01 | 0 | Profit |
| Sept 2023 | 0.07 | 0 | Profit |
| Mar 2023 | -0.26 | 0 | Loss |
Healthcare Peers with Valid P/E Ratios — VIVANZA Comparison
Healthcare sector average P/E 49.25, median 27.32 — VIVANZA excluded (negative EPS).
Sector Average PE
49.25
Sector Median PE
27.32
Lowest PE
1.17
Profitable Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 6.78 | ₹73 | Low |
| Zenith Drugs | ZENITHDRUG | 7.55 | ₹73 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Medicamen Organics | MEDIORG | 8.01 | ₹32 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Vasundhara Rasayans | VRL | 11.05 | ₹40 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see VIVANZA stock overview.
- Analyse VIVANZA shareholding pattern to track promoter, FII and institutional holdings.
- View VIVANZA price range for the annual high/low range and current price position.